GranuFlo Lawsuits Continue to Rise Amid the News That Fresenius Did Not Inform the FDA Until After the Clinics Were Told
For those taking GranuFlo during kidney dialysis, thought they were taking a drug that would improve their quality of life. Instead, they took a drug that significantly increased the risk of heart problems, including cardiac arrest and cardiopulmonary death. In response to these deaths, the FDA issued a Class 1 recall of the drug in March 2012. Now, many people have filed GranuFlo lawsuits in order to get compensation for the wrongful death of their loved ones.
View full press release